Madigan Army Medical Center
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Madigan Army Medical Center sits in the top decile of US sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count).
Madigan Army Medical Center: 22 sponsored US clinical trials, 4 recruiting.
Madigan Army Medical Center sponsors 22 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 13 completed. 7 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypovitaminosis D, with 2 trials.
Top-decile sponsor footprint
Madigan Army Medical Center ranks in the top decile of sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
22 total, page 1 of 1
Simethicone as Part of ERAS in Bariatric Surgery Patients
NCT06812832
Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel
NCT07199829
Antiseptic Effects on the Dental Implant Internal Surface Microbiome
NCT05024760
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
NCT04704297
Dupixent Study for Alternate Administration
NCT06750471
Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram
NCT05190341
STI/HIV Intervention Behavioral Intervention Program
NCT04547413
Precision Nutrition Impact on Health-Related Behavior Change
NCT04959318
Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation
NCT04556136
Uncontrolled Hypertension Management (TEAM-HTN)
NCT03281772
Vitamin D Supplementation in Warfighters
NCT02954549
Sinasprite: A Pilot Feasibility Study for Patients With Anxiety or Stress
NCT02955784
The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months
NCT02221895
A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial
NCT01993615
A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis
NCT01427153
Comparative Effectiveness of Early Physical Therapy Versus Usual Care for Low Back Pain
NCT01556581
Physical Therapy Versus Steroid Injection for Shoulder Impingement Syndrome
NCT01190891
Elective Induction of Nulliparous Labor
NCT01076062
Simplified Technique for Performing Laparoscopic Gastric Bypass
NCT06782256
Medical Therapies for Chronic Post-Traumatic Headaches
NCT00862095
Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel
NCT00659204
Misoprostol for Non-Viable Pregnancies
NCT00426491
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
| Phase 4 | 5 |
Therapeutic Areas
Where Madigan Army Medical Center enrollment is open (later-stage tilt)
4 recruiting of 22 indexed (18% open); 13 completed (59%).
Phase mix: 7 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Hypovitaminosis D (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Madigan Army Medical Center: open-pipeline peers nationwide
Peers matched on 22 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Madigan Army Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 22 trials (± recruiting share)
- Alaunos Therapeutics · 22 trials · 0% recruiting
- Alexza Pharmaceuticals · 22 trials · 0% recruiting
- Calithera Biosciences · 22 trials · 0% recruiting
- Fate Therapeutics · 22 trials · 14% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
- Imunon · 18% recruiting · 11 trials
- InventisBio Co. · 18% recruiting · 11 trials
Related
What to do with this Madigan Army Medical Center page
22 registered trials is a research-attention snapshot, not an endorsement of Madigan Army Medical Center or any single study.
- 4 of Madigan Army Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypovitaminosis D is the condition Madigan Army Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypovitaminosis D trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Madigan Army Medical Center pipeline card: 22 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.